Transfusion Medicine And Hemotherapy impact factor, indexing, ranking (2025)

---

Aim and Scope

The Transfusion Medicine And Hemotherapy is a research journal that publishes research related to Medicine. This journal is published by the S. Karger AG. The ISSN of this journal is 14245493, 16603796. Based on the Scopus data, the SCImago Journal Rank (SJR) of transfusion medicine and hemotherapy is 0.814.

Also, please check the following important details about transfusion medicine and hemotherapy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Transfusion Medicine And Hemotherapy Ranking

The latest Impact Factor list (JCR) was released in June 2025.

The Impact Factor of Transfusion Medicine And Hemotherapy is 1.9.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title:	Transfusion Medicine and Hemotherapy
Publisher:	S. Karger AG
ISSN:	14245493, 16603796
Type:	journal
Journal Scope:	Medicine
Country:	Switzerland
H-Index:	50
SJR:	0.814
Quartile:	Hematology (Q2); Immunology and Allergy (Q2)

Indexing

The transfusion medicine and hemotherapy is indexed in:

• UGC CARE
• Scopus
• Web of Science (SCIE)
• DOAJ
• PubMed
• Embase

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Transfusion Medicine And Hemotherapy Impact Factor 2025

The latest impact factor of transfusion medicine and hemotherapy is 1.9 which was recently updated in June, 2025.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2025.

Quartile

The latest Quartile of transfusion medicine and hemotherapy is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Publication fee

According to journal website, the publication fee of transfusion medicine and hemotherapy is around 1580 CHF; 1750 USD; 1510 EUR.

The transfusion medicine and hemotherapy has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the transfusion medicine and hemotherapy publishes research articles in 21 weeks on an average.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Transfusion Medicine And Hemotherapy?

If your research is related to Medicine, then visit the official website of transfusion medicine and hemotherapy and send your manuscript.

Tips for publishing in Transfusion Medicine And Hemotherapy:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

Sources: https://www.karger.com/tmh

---